Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm?

被引:35
作者
Ohtaka, A
Ootaka, T
Sato, H
Ito, S
机构
[1] Tohoku Univ, Dept Nephrol, Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Dept Med Technol, Coll Med Sci, Sendai, Miyagi 9808574, Japan
关键词
cellular lesion; Pax2; phenotypic change; primary focal segmental glomerulosclerosis; WT1;
D O I
10.1093/ndt/17.suppl_9.11
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
WT1 and Pax2 are transcription factors involved in kidney development and phenotypic regulation of glomerular epithelial cells. In primary focal segmental glomerulosclerosis (FSGS), the alteration of the podocyte is important for the development of the cellular lesion (CL) and glomerular scar formation. To investigate the contribution of WT1 and Pax2 to the development of the CL in primary FSGS, immunohistological studies were performed using renal biopsy specimens on the expression of WT1, Pax2 and cytokeratin (CK), which is an epithelial marker but never found in normal podocytes. The expression of WT1 was decreased in the CL compared with unaffected podocytes, but Pax2 and CK were expressed significantly in the CL and also in the cells morphologically recognized as podocytes in cases with CL. Our results suggest that re-expression of Pax2 resulting in phenotypic change of podocytes to a different epithelial form is important for the development of the CL in primary FSGS. Normal podocytes resemble mesenchymal cells since they express both vimentin and WT1. In contrast, epithelial cells including parietal epithelial cells of the Bowman's capsule express both Pax2 and CK. Therefore, the mechanism of phenotypic change of podocytes in the CL in primary FSGS might be mesenchymal-epithelial transformation and a developmental paradigm.
引用
收藏
页码:11 / 15
页数:5
相关论文
共 28 条
[1]   Donor splice-site mutations in WT1 are responsible for Frasier syndrome [J].
Barbaux, S ;
Niaudet, P ;
Gubler, MC ;
Grunfeld, JP ;
Jaubert, F ;
Kuttenn, F ;
Fekete, CN ;
SouleyreauTherville, N ;
Thibaud, E ;
Fellous, M ;
McElreavey, K .
NATURE GENETICS, 1997, 17 (04) :467-470
[2]  
Barisoni L, 1999, J AM SOC NEPHROL, V10, P51
[3]  
Cameron JS, 1996, KIDNEY INT, V50, pS119
[4]   THE MANY MASKS OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS [J].
DAGATI, V .
KIDNEY INTERNATIONAL, 1994, 46 (04) :1223-1241
[5]  
Denamur E, 1999, J AM SOC NEPHROL, V10, P2219
[6]   COLLAPSING GLOMERULOPATHY - A CLINICALLY AND PATHOLOGICALLY DISTINCT VARIANT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS [J].
DETWILER, RK ;
FALK, RJ ;
HOGAN, SL ;
JENNETTE, JC .
KIDNEY INTERNATIONAL, 1994, 45 (05) :1416-1424
[7]   PAX-2 IS A DNA-BINDING PROTEIN EXPRESSED IN EMBRYONIC KIDNEY AND WILMS-TUMOR [J].
DRESSLER, GR ;
DOUGLASS, EC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (04) :1179-1183
[8]   DEREGULATION OF PAX-2 EXPRESSION IN TRANSGENIC MICE GENERATES SEVERE KIDNEY ABNORMALITIES [J].
DRESSLER, GR ;
WILKINSON, JE ;
ROTHENPIELER, UW ;
PATTERSON, LT ;
WILLIAMSSIMONS, L ;
WESTPHAL, H .
NATURE, 1993, 362 (6415) :65-67
[9]  
GRUBB GR, 1994, LAB INVEST, V71, P472
[10]   Origin of hyperplastic epithelial cells in idiopathic collapsing glomerulopathy [J].
Kihara, I ;
Yaoita, E ;
Kawasaki, K ;
Yamamoto, T ;
Hara, M ;
Yanagihara, T .
HISTOPATHOLOGY, 1999, 34 (06) :537-547